Depends what you mean by risk-averse. Alcor has an unquestionable history of fighting for its members’ wishes, rather than giving up on them at the mere hint of a legal battle. The only way in which CI could be said to be more financially prudent (but in a way with its own costs) is in its remarkable ability to hold down operating costs. I’m working hard on reducing our costs without undesirable penalties in terms of capabilities. I think we are also now at a point where further membership growth will yield significant economies of scale.
But take a look at both organizations’ financial statements. You will see that CI expects to maintain patients indefinitely—and revive them—on a small amount of per-patient funding. That takes some heroic and highly risky assumptions to accept. Alcor has carefully structured institutions and policies to manage sustainably for the long-term, including strict limits on what can be charged to the patient care trust fund, a 2% draw on the Endowment Fund, and an investment policy that has been giving us gains (while CI has been losing on its investments). If you continue to delve into the gory details, I think you may continue to update your views further.
Depends what you mean by risk-averse. Alcor has an unquestionable history of fighting for its members’ wishes, rather than giving up on them at the mere hint of a legal battle. The only way in which CI could be said to be more financially prudent (but in a way with its own costs) is in its remarkable ability to hold down operating costs. I’m working hard on reducing our costs without undesirable penalties in terms of capabilities. I think we are also now at a point where further membership growth will yield significant economies of scale.
But take a look at both organizations’ financial statements. You will see that CI expects to maintain patients indefinitely—and revive them—on a small amount of per-patient funding. That takes some heroic and highly risky assumptions to accept. Alcor has carefully structured institutions and policies to manage sustainably for the long-term, including strict limits on what can be charged to the patient care trust fund, a 2% draw on the Endowment Fund, and an investment policy that has been giving us gains (while CI has been losing on its investments). If you continue to delve into the gory details, I think you may continue to update your views further.